Evidence map›Paper›PMID 36045225›Full record

ReviewNature protocols2022

Synthesis of cyclodextrin derivatives for enantiodifferentiating photocyclodimerization of 2-anthracenecarboxylate.

Xueqin Wei, Jiecheng Ji, Yongxin Nie, Liangjian Tang, Ming Rao, Xiaoqian Wang, Wanhua Wu, Dan Su, Zhihui Zhong, Cheng Yang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueqin Wei *Key Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Jiecheng Ji *Key Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yongxin NieGuangxi Key Laboratory of Bioactive Molecules Research and Evaluation, School of Pharmacy, Guangxi Medical University, Nanning, China.
Liangjian TangGuangxi Key Laboratory of Bioactive Molecules Research and Evaluation, School of Pharmacy, Guangxi Medical University, Nanning, China.
Ming RaoKey Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Xiaoqian WangKey Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Wanhua WuKey Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. wuwanhua@scu.edu.cn.ORCID http://orcid.org/0000-0002-8969-1148
Dan SuKey Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Zhihui ZhongKey Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Cheng YangKey Laboratory of Green Chemistry and Technology, College of Chemistry, Huaxi MR Research Center (HMRRC), Department of Radiology, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. yangchengyc@scu.edu.cn.ORCID http://orcid.org/0000-0002-2049-1324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photochemical methods are increasingly being used in organic synthesis. They are especially useful for preparing many compounds that are not readily accessible through thermal or enzymatic reactions. The supramolecular strategy has proved highly promising in recent years for manipulating the stereochemical outcome of chiral photoreactions through relatively strong and long-lasting noncovalent interactions in both ground and excited states. Among the numerous chiral photochemical reactions, photocyclodimerization of 2-anthracenecarboxylate (AC) is the most comprehensively studied supramolecular chiral photoreaction and has essentially become a benchmark reaction for evaluating supramolecular photochirogenesis. Cyclodextrin (CD) derivatives were the earliest and are the most widely applied chiral host for mediating photoreactions. Herein, we use CD-mediated photocyclodimerization of AC as an example to introduce the operation process of supramolecular chiral photoreactions. The protocol includes the following contents: (i) the preparation, purification and characterization of β-CD derivatives; (ii) methods for investigating the host-guest inclusion behavior between AC and β-CD derivatives; (iii) the photochemical reaction operation flow under different solvent and temperature conditions; (iv) chiral high-performance liquid chromatography (HPLC) analyses of the product distribution and enantioselectivity. The protocol is introduced by using representative examples of the synthesis of β-CD derivatives and the manipulation of environmental factors that give excellent regio- and enantioselectivities in the photocyclodimerization of AC. The synthesis and purification of β-CD derivatives require 3-5 d of work. The photoirradiation of AC with β-CD derivatives can be done within 1 h. The product analysis requires 5 h.

Indexed as

CyclodextrinsAnthracenesCarboxylic AcidsCyclizationDimerizationStereoisomerism2-anthracenecarboxylateAnthracenesCarboxylic AcidsCyclodextrins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.